The approved GLP-1 class medications as of 2025 include semaglutide (Wegovy for obesity, Ozempic for type 2 diabetes), tirzepatide (Zepbound for obesity, Mounjaro for type 2 diabetes), and oral semaglutide (Rybelsus, now in a higher-dose formulation as Wegovy oral)
In addition to reversing your deficiency, these injections restore energy levels, fix your metabolism, and alleviate any neurological symptoms
A 2020 meta-analysis in Obesity Reviews found that patients who implemented structured caloric monitoring before GLP-1 cessation retained 40% more of their weight loss at six months compared to those who began dietary interventions only after stopping [9]
Peer review involves independent experts evaluating methodology, data analysis, and conclusions before publication
They maintain strength and contribute to soil enrichment and energy recovery, making them a perfect, eco-conscious choice for your daily lip care routine